Mirum Pharmaceuticals (MIRM) Operating Leases (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Operating Leases of $11.2 million for Q1 2026, up 59.57% year-over-year from $7.0 million in Q1 2025, and up 48.68% quarter-over-quarter from $7.5 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Operating Leases (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- In Q1 2026, Operating Leases rose 59.57% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 59.57% YoY), while the FY2025 annual figure was $7.5 million, down 5.72% from the prior year.
- Operating Leases for Q1 2026 stood at $11.2 million, up from $7.5 million in the prior quarter.
- The five-year high for Operating Leases was $11.2 million in Q1 2026, with the low at $617000.0 in Q4 2023.
- The 5-year median for Operating Leases is $1.7 million (2022), against an average of $4.8 million.
- The sharpest annual moves came in 2023 and 2024: Operating Leases plunged 50.91% in 2023, then soared 1192.06% in 2024.
- Mirum Pharmaceuticals' Operating Leases stood at $1.3 million in 2022, then slumped by 50.91% to $617000.0 in 2023, then jumped by 1192.06% to $8.0 million in 2024, then declined by 5.72% to $7.5 million in 2025, then jumped by 48.68% to $11.2 million in 2026.
- Business Quant data shows MIRM's Operating Leases at $11.2 million in Q1 2026, $7.5 million in Q4 2025, and $9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.87 Mn |
| Mar 31, 2026 | 11.18 Mn |
| Dec 31, 2025 | 7.52 Mn |
| Sep 30, 2025 | 9.40 Mn |
| Jun 30, 2025 | 9.97 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 8.24 Mn |
| Mar 31, 2024 | 686,000.00 |
| Dec 31, 2023 | 617,000.00 |
| Sep 30, 2023 | 868,000.00 |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 2.09 Mn |